Artiva Biotherapeutics, Inc.
ARTV
$2.47
$0.020.82%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -16.10M | -17.47M | -17.84M | -13.96M | -12.00M |
| Total Depreciation and Amortization | 614.00K | 627.00K | 603.00K | 587.00K | 594.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.14M | 2.23M | 3.56M | 1.31M | 1.82M |
| Change in Net Operating Assets | -311.00K | 3.01M | -7.00K | -3.02M | -1.09M |
| Cash from Operations | -14.65M | -11.61M | -13.69M | -15.09M | -10.68M |
| Capital Expenditure | -64.00K | -96.00K | -464.00K | -18.00K | -636.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -902.00K | -130.53M | 1.81M | 9.80M | -2.03M |
| Cash from Investing | -966.00K | -130.63M | 1.35M | 9.78M | -2.67M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -33.00K | -38.00K | -78.00K | -- | -- |
| Issuance of Common Stock | 23.00K | 166.51M | 22.00K | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -20.00K | -2.60M | -1.56M | -- | 962.00K |
| Cash from Financing | -30.00K | 163.87M | -1.62M | -- | 962.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.65M | 21.63M | -13.95M | -5.30M | -12.38M |